This innovative Multilevel Action Toward Colorectal Cancer (CRC) and Hepatitis C Virus (HCV) Education and Screening (MATCHES) intervention aims to promote concurrent HCV and CRC screening among FQHC patients ages 45-75.
While this is a multi-level intervention study, only information related to the patient-level intervention is being reported for the purposes ClinicalTrials.gov.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SCREENING
Masking
NONE
Enrollment
350
Participants will be asked to complete a survey with specific topics including Hepatitis C (HCV) and Colorectal (CRC) knowledge and health beliefs, screening intentions and demographic characteristics. Participants will be provided with education intervention materials (for example, a booklet) either in-person or via mail, access to free stool-based CRC screening, and access to free HCV screening. Approximately 1-2 weeks after receiving the education materials, participants will be asked to complete a post-intervention survey about the same specific topics (for example, HCV and CRC knowledge, HCV and CRC health beliefs, HCV and CRC screening intentions, healthcare experiences, perceptions of the educational materials) over the phone with a trained study staff. Participants with a positive HCV screening and/or CRC screening result will be navigated to follow-up care as needed.
Moffitt Cancer Center
Tampa, Florida, United States
RECRUITINGScreening Uptake for Hepatitis C Virus (HCV) and Colorectal Cancer (CRC)
Screening Uptake will be measured by the number of participants who complete both CRC and HCV screening documented via Electronic Health Record (EHR) at 12 months post-intervention.
Time frame: Up to 12 Months
Screening Completion for Hepatitis C Virus (HCV)
Screening Completion for HCV will be measured by the number of participants who complete HCV Screening at any time during the Study Period.
Time frame: Up to 41 Months
Screening Completion for Colorectal Cancer (CRC)
Screening Completion for CRC will be measured by the number of participants who complete CRC Screening at any time during the Study Period.
Time frame: Up to 41 Months
Screening Test Results for Hepatitis C (HCV)
Screening Test Results will be measured as abnormal vs normal
Time frame: Up to 41 Months
Screening Test Results for Colorectal Cancer (CRC)
Screening Test Results will be measured as abnormal vs normal
Time frame: Up to 41 Months
Completion of repeat CRC Screening
Completion of any repeat CRC Screening will be measured by the number of participants who repeat CRC Screening during the Study interval.
Time frame: Up to 41 Months
Shannon Christy, PhD
CONTACT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.